Mina Bissell

The Scientist Date: July 22, 1996 THE SCIENTIST® The Newspaper for the Life Sciences Professional "Science is inseparable from other issues that confront us in our daily lives, and THE SCIENTIST presents both sides of controversial issues thoroughly....THE SCIENTIST tells our stories." Mina Bissell, director, Life Sciences Division, Berkeley National Laboratory; president-elect, American Society for Cell Biology, Washington, D.C. From the outset of her career as a scientist, Mina Bissell

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The Scientist

Date: July 22, 1996

Mina Bissell, director, Life Sciences Division, Berkeley National Laboratory; president-elect, American Society for Cell Biology, Washington, D.C.

From the outset of her career as a scientist, Mina Bissell has been an iconoclast. For the past 25 years, she has been engaged in understanding how a normal cell remains normal in order to comprehend how a cell becomes malignant. In 1981, based on her work with cultured cells, Bissell developed the concept that the differentiated state of normal cells is unstable. In 1982, she proposed a model of "dynamic reciprocity," which argued that the microenvironment-and specifically the extracellular matrix (ECM)-has crucial information for functional differentiation. In the last 14 years, she and her colleagues not only have proved this concept but also have shown the central role of ECM in programmed cell death (apoptosis) and cancer. Bissell credits the U.S. Department of Energy's Office of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies